{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:05:37Z","timestamp":1787022337104,"version":"build-2736575974"},"reference-count":66,"publisher":"Pacini Editore","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-n2422","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T13:22:31Z","timestamp":1684934551000},"page":"324-340","source":"Crossref","is-referenced-by-count":15,"title":["Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics","Raccomandazioni pratiche nella gestione ambulatoriale della rinosinusite cronica con poliposi nasale severa, nell\u2019era dei biologici"],"prefix":"10.14639","volume":"43","author":[{"given":"Eugenio","family":"De Corso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Pipolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cantone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Ottaviano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Torretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lucidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Seccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Settimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Rikki Mauritz","family":"Canevari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"La Mantia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Garzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Bellocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Macchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Malvezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Maselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Dell\u2019Era","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Dragonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Asprea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lupato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ghidini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Masieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Mattavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Antonio","family":"Salzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiderio","family":"Passali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pagella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20340","published-online":{"date-parts":[[2023,10]]},"reference":[{"key":"10.14639\/0392-100X-N2422_ref1","doi-asserted-by":"crossref","unstructured":"Bachert C, Bhattacharyya N, Desrosiers M, et al. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy 2021;14:127-134. https:\/\/doi.org\/10.2147\/JAA.S290424","DOI":"10.2147\/JAA.S290424"},{"key":"10.14639\/0392-100X-N2422_ref2","doi-asserted-by":"crossref","unstructured":"De Corso E, Bellocchi G, De Benedetto M, et al. Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology. Acta Otorhinolaryngol Ital 2022;42:1-16. https:\/\/doi.org\/10.14639\/0392-100X-N1614","DOI":"10.14639\/0392-100X-N1614"},{"key":"10.14639\/0392-100X-N2422_ref3","doi-asserted-by":"crossref","unstructured":"Zhou F, Zhang T, Jin Y, et al. Developments and emerging trends in the global treatment of chronic rhinosinusitis from 2001 to 2020: a systematic bibliometric analysis. Front Surg 2022;9:851923. https:\/\/doi.org\/10.3389\/fsurg.2022.851923","DOI":"10.3389\/fsurg.2022.851923"},{"key":"10.14639\/0392-100X-N2422_ref4","doi-asserted-by":"crossref","unstructured":"Rimmer J, Hellings P, Lund VJ, et al. European position paper on diagnostic tools in rhinology. Rhinology 2019;57(Suppl. S28):1-41. https:\/\/doi.org\/10.4193\/Rhin19.410","DOI":"10.4193\/Rhin19.410"},{"key":"10.14639\/0392-100X-N2422_ref5","doi-asserted-by":"crossref","unstructured":"De Corso E, Bilo MB, Matucci A, et al. Personalized management of patients with chronic rhinosinusitis with nasal polyps in clinical practice: a multidisciplinary consensus statement. J Pers Med 2022;12:846. https:\/\/doi.org\/10.3390\/jpm12050846","DOI":"10.3390\/jpm12050846"},{"key":"10.14639\/0392-100X-N2422_ref6","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy 2019;74:2312-2319. https:\/\/doi.org\/10.1111\/all.13875","DOI":"10.1111\/all.13875"},{"key":"10.14639\/0392-100X-N2422_ref7","doi-asserted-by":"crossref","unstructured":"Millarelli S, Loperfido A, Mammarella F, et al. A practical clinical protocol for monitoring patients with severe uncontrolled chronic rhinosinusitis with nasal polyposis treated with biologics. Allergy Rhinol (Providence) 2022;13:21526567221074335. https:\/\/doi.org\/10.1177\/21526567221074335","DOI":"10.1177\/21526567221074335"},{"key":"10.14639\/0392-100X-N2422_ref8","doi-asserted-by":"crossref","unstructured":"Lombardi C, Asero R, Bagnasco D, et al. ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments. World Allergy Organ J 2021;14:100592. https:\/\/doi.org\/10.1016\/j. waojou.2021.100592","DOI":"10.1016\/j.waojou.2021.100592"},{"key":"10.14639\/0392-100X-N2422_ref9","doi-asserted-by":"crossref","unstructured":"Hopkins C, McKenzie JL, Anari S, et al. British Rhinological Society consensus guidance on the use of biological therapies for chronic rhi-nosinusitis with nasal polyps. Clin Otolaryngol 2021;46:1037-1043. https:\/\/doi.org\/10.1111\/coa.13779","DOI":"10.1111\/coa.13779"},{"key":"10.14639\/0392-100X-N2422_ref10","doi-asserted-by":"crossref","unstructured":"Klimek L, F\u00f6rster-Ruhrmann U, Beule AG, et al. Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP). Allergo J Int 2022;31:149-160. https:\/\/doi.org\/10.1007\/s40629-022-00220-x.10.1007\/s40629-022-00220-x","DOI":"10.1007\/s40629-022-00220-x"},{"key":"10.14639\/0392-100X-N2422_ref11","doi-asserted-by":"crossref","unstructured":"Thamboo A, Kilty S, Witterick I, et al. Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis. Otolaryngol Head Neck Surg 2021;50:15. https:\/\/doi.org\/10.1186\/s40463-021-00493-2","DOI":"10.1186\/s40463-021-00493-2"},{"key":"10.14639\/0392-100X-N2422_ref12","doi-asserted-by":"crossref","unstructured":"Lou H, Zhang N, Bachert C, et al. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. Int Forum Allergy Rhinol 2018;8:1218-1225. https:\/\/doi.org\/10.1002\/alr.22214","DOI":"10.1002\/alr.22214"},{"key":"10.14639\/0392-100X-N2422_ref13","doi-asserted-by":"crossref","unstructured":"Brescia G, Sfriso P, Marioni G. Role of blood inflammatory cells in chronic rhinosinusitis with nasal polyps. Acta Otolaryngol 2019;139:48-51. https:\/\/doi.org\/10.1080\/00016489.2018.1538567","DOI":"10.1080\/00016489.2018.1538567"},{"key":"10.14639\/0392-100X-N2422_ref14","doi-asserted-by":"crossref","unstructured":"De Corso E, Settimi S, Tricarico L, et al. Predictors of disease control after endoscopic sinus surgery plus long-term local corticosteroids in CRSwNP. Am J Rhinol Allergy 2021;35:77-85. https:\/\/doi.org\/10.1177\/1945892420936196","DOI":"10.1177\/1945892420936196"},{"key":"10.14639\/0392-100X-N2422_ref15","doi-asserted-by":"crossref","unstructured":"Heffernan A, Phulka J, Thamboo A. Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era. J Otolaryngol Head Neck Surg 2022;51:22. https:\/\/doi.org\/10.1186\/s40463-022-00580-y","DOI":"10.1186\/s40463-022-00580-y"},{"key":"10.14639\/0392-100X-N2422_ref16","doi-asserted-by":"crossref","unstructured":"Caruso C, Colantuono S, Ciasca G, et al. Different aspects of severe asthma in real life: role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity. Allergy 2023;78:131-140. https:\/\/doi.org\/10.1111\/all.15466","DOI":"10.1111\/all.15466"},{"key":"10.14639\/0392-100X-N2422_ref17","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 2020;58(Suppl S29):1-464. https:\/\/doi.org\/10.4193\/Rhin20.600","DOI":"10.4193\/Rhin20.600"},{"key":"10.14639\/0392-100X-N2422_ref18","doi-asserted-by":"crossref","unstructured":"De Corso E, Baroni S, Settimi S, et al. Sinonasal biomarkers defining type 2-high and type 2-low inflammation in chronic rhinosinusitis with nasal polyps. J Pers Med 2022;12:1251. https:\/\/doi.org\/10.3390\/jpm12081251","DOI":"10.3390\/jpm12081251"},{"key":"10.14639\/0392-100X-N2422_ref19","doi-asserted-by":"crossref","unstructured":"De Corso E, Baroni S, Lucidi D, et al. Nasal lavage levels of granulocyte-macrophage colony-stimulating factor and chronic nasal hypereosinophilia. Int Forum Allergy Rhinol 2015;5:557-562. https:\/\/doi.org\/10.1002\/alr.21519","DOI":"10.1002\/alr.21519"},{"key":"10.14639\/0392-100X-N2422_ref20","doi-asserted-by":"crossref","unstructured":"De Corso E, Baroni S, Battista M, et al. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation. Int Forum Allergy Rhinol 2014;4:617-624. https:\/\/doi.org\/10.1002\/alr.21348","DOI":"10.1002\/alr.21348"},{"key":"10.14639\/0392-100X-N2422_ref21","doi-asserted-by":"crossref","unstructured":"De Corso E, Baroni S, Romitelli F, et al. Nasal lavage CCL24 levels correlate with eosinophils trafficking and symptoms in chronic sino-nasal eosinophilic inflammation. Rhinology 2011;49:174-179. https:\/\/doi.org\/10.4193\/Rhino10.133","DOI":"10.4193\/Rhino10.133"},{"key":"10.14639\/0392-100X-N2422_ref22","doi-asserted-by":"crossref","unstructured":"Gallo S, Castelnuovo P, Spirito L, et al. Mepolizumab improves outcomes of chronic rhinosinusitis with nasal polyps in severe asthmatic patients: a multicentric real-life study. J Pers Med 2022;12:1304. https:\/\/doi.org\/10.3390\/jpm12081304","DOI":"10.3390\/jpm12081304"},{"key":"10.14639\/0392-100X-N2422_ref23","doi-asserted-by":"crossref","unstructured":"Seccia V, D\u2019Amato M, Scioscia G, et al. Management of patients with severe asthma and chronic rhinosinusitis with nasal polyps: a multidisciplinary shared approach. J Pers Med 2022;12:1096. https:\/\/doi.org\/10.3390\/jpm12071096","DOI":"10.3390\/jpm12071096"},{"key":"10.14639\/0392-100X-N2422_ref24","doi-asserted-by":"crossref","unstructured":"Racette SD, Schneider AL, Ganesh M, et al. CRS-PRO and SNOT-22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis. Int Forum Allergy Rhinol 2022;12:1377-1386. https:\/\/doi.org\/10.1002\/alr.23002","DOI":"10.1002\/alr.23002"},{"key":"10.14639\/0392-100X-N2422_ref25","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology 2020;58:82-111. https:\/\/doi.org\/10.4193\/Rhin20.601","DOI":"10.4193\/Rhin20.601"},{"key":"10.14639\/0392-100X-N2422_ref26","doi-asserted-by":"crossref","unstructured":"Phillips KM, Singerman KW, Sedaghat AR. Individual symptom visual analogue scale severity scores for determining EPOS guideline-based chronic rhinosinusitis disease control. Rhinology 2022;60:229-235. https:\/\/doi.org\/10.4193\/Rhin21.446","DOI":"10.4193\/Rhin21.446"},{"key":"10.14639\/0392-100X-N2422_ref27","doi-asserted-by":"crossref","unstructured":"Peters AT, Soler ZM, Kern RC, et al. Improvement in patient-reported \u201ctaste\u201d and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials. Clin Exp Allergy 2022;52:1105-1109. https:\/\/doi.org\/10.1111\/cea.14194","DOI":"10.1111\/cea.14194"},{"key":"10.14639\/0392-100X-N2422_ref28","doi-asserted-by":"crossref","unstructured":"Bachert C, Peters AT, Heffler E, et al. Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies. Clin Exp Allergy 2022;52:244-249. https:\/\/doi.org\/10.1111\/cea.14051","DOI":"10.1111\/cea.14051"},{"key":"10.14639\/0392-100X-N2422_ref29","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, Mullol J, Kennedy D, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In-depth sinus surgery analysis. Allergy 2023;78:812-821. https:\/\/doi.org\/10.1111\/all.15434","DOI":"10.1111\/all.15434"},{"key":"10.14639\/0392-100X-N2422_ref30","doi-asserted-by":"crossref","unstructured":"Chen T, Chidarala S, Young G, et al. Association of sinonasal computed tomography scores to patient-reported outcome measures: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2023;168:628-634. https:\/\/doi.org\/10.1177\/01945998221114078","DOI":"10.1177\/01945998221114078"},{"key":"10.14639\/0392-100X-N2422_ref31","doi-asserted-by":"crossref","unstructured":"Ottaviano G, Pendolino AL, Scarpa B, et al. Correlations between peak nasal inspiratory flow, acoustic rhinometry, 4-Phase rhinomanometry and reported nasal symptoms. J Pers Med 2022;12:1513. https:\/\/doi.org\/10.3390\/jpm12091513","DOI":"10.3390\/jpm12091513"},{"key":"10.14639\/0392-100X-N2422_ref32","doi-asserted-by":"crossref","unstructured":"De Corso E, Pipolo C, Cantone E, et al. Survey on use of local and systemic corticosteroids in the management of chronic rhinosinusitis with nasal polyps: identification of unmet clinical needs. J Pers Med 2022;12:897. https:\/\/doi.org\/10.3390\/jpm12060897","DOI":"10.3390\/jpm12060897"},{"key":"10.14639\/0392-100X-N2422_ref33","doi-asserted-by":"crossref","unstructured":"Ma L, Shi J, Wang K, et al. Clinical characteristics of patients with CRSwNP with intensely high eosinophil level. Laryngoscope Investig Otolaryngol 2022;7:316-324. https:\/\/doi.org\/10.1002\/lio2.758","DOI":"10.1002\/lio2.758"},{"key":"10.14639\/0392-100X-N2422_ref34","doi-asserted-by":"crossref","unstructured":"De Corso E, Lucidi D, Cantone E, et al. Clinical evidence and biomarkers linking allergy and acute or chronic rhinosinusitis in children: a systematic review. Curr Allergy Asthma Rep 2020;20:68. https:\/\/doi.org\/10.1007\/s11882-020-00967-9","DOI":"10.1007\/s11882-020-00967-9"},{"key":"10.14639\/0392-100X-N2422_ref35","doi-asserted-by":"crossref","unstructured":"De Corso E, Lucidi D, Battista M, et al. Prognostic value of nasal cytology and clinical factors in nasal polyps development in patients at risk: can the beginning predict the end? Int Forum Allergy Rhinol 2017;7:861-867. https:\/\/doi.org\/10.1002\/alr.21979","DOI":"10.1002\/alr.21979"},{"key":"10.14639\/0392-100X-N2422_ref36","doi-asserted-by":"crossref","unstructured":"De Corso E, Baroni S, Onori ME, et al. Calprotectin in nasal secretion: a new biomarker of non-type 2 inflammation in CRSwNP. Acta Otorhinolaryngol Ital 2022;42:355-363. https:\/\/doi.org\/10.14639\/0392-100X-N1800","DOI":"10.14639\/0392-100X-N1800"},{"key":"10.14639\/0392-100X-N2422_ref37","doi-asserted-by":"crossref","unstructured":"De Corso E, Seccia V, Ottaviano G, et al. Clinical evidence of type 2 inflammation in non-allergic rhinitis with eosinophilia syndrome: a systematic review. Curr Allergy Asthma Rep 2022;22:29-42. https:\/\/doi.org\/10.1007\/s11882-022-01027-0","DOI":"10.1007\/s11882-022-01027-0"},{"key":"10.14639\/0392-100X-N2422_ref38","doi-asserted-by":"crossref","unstructured":"Marchese-Ragona R, Restivo DA, De Corso E, et al. Loss of smell in COVID-19 patients: a critical review with emphasis on the use of olfactory tests. Acta Otorhinolaryngol Ital 2020;40:241-247. https:\/\/doi.org\/10.14639\/0392-100X-N0862","DOI":"10.14639\/0392-100X-N0862"},{"key":"10.14639\/0392-100X-N2422_ref39","doi-asserted-by":"crossref","unstructured":"Ottaviano G, Frasson G, Nardello E, et al. Olfaction deterioration in cognitive disorders in the elderly. Aging Clin Exp Res 2016;28:37-45. https:\/\/doi.org\/10.1007\/s40520-015-0380-x","DOI":"10.1007\/s40520-015-0380-x"},{"key":"10.14639\/0392-100X-N2422_ref40","doi-asserted-by":"crossref","unstructured":"Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol 2016;56:1-30. https:\/\/doi.org\/10.4193\/Rhino16.248","DOI":"10.4193\/Rhino16.248"},{"key":"10.14639\/0392-100X-N2422_ref41","doi-asserted-by":"crossref","unstructured":"Cantone E, De Corso E, Ricciardiello F, et al. Olfaction recovery following dupilumab is independent of nasal polyp reduction in CRSwNP. J Pers Med 2022;12:1215. https:\/\/doi.org\/10.3390\/jpm12081215","DOI":"10.3390\/jpm12081215"},{"key":"10.14639\/0392-100X-N2422_ref42","doi-asserted-by":"crossref","unstructured":"Briner HR, Jones N, Simmen D. Olfaction after endoscopic sinus surgery: long-term results. Rhinology 2012;50:178-184. https:\/\/doi.org\/10.4193\/Rhino11.213","DOI":"10.4193\/Rhino11.213"},{"key":"10.14639\/0392-100X-N2422_ref43","doi-asserted-by":"crossref","unstructured":"Ramaswamy US, Patel VA, Lee SE. Managing chronic rhinosinusitis in severe asthma. Curr Opin Pulm Med 2021;27:23-28. https:\/\/doi.org\/10.1097\/MCP.0000000000000741","DOI":"10.1097\/MCP.0000000000000741"},{"key":"10.14639\/0392-100X-N2422_ref44","doi-asserted-by":"crossref","unstructured":"Canonica GW, Malvezzi L, Blasi F, et al. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: evidences from the Severe Asthma Network Italy (SANI) registry. Respir Med 2020;166:105947. https:\/\/doi.org\/10.1016\/j.rmed.2020.105947","DOI":"10.1016\/j.waojou.2020.100379"},{"key":"10.14639\/0392-100X-N2422_ref45","doi-asserted-by":"crossref","unstructured":"Li KL, Fang CH, Ferastraoaru D, et al. Patient satisfaction and efficiency benefits of a novel multidisciplinary rhinology and allergy clinic. Ann Otol Rhinol Laryngol 2020;129:699-706. https:\/\/doi.org\/10.1177\/0003489420905859","DOI":"10.1177\/0003489420905859"},{"key":"10.14639\/0392-100X-N2422_ref46","unstructured":"La Mantia I, Ciprandi G, Varricchio A, et al. When rhinosinusitis is not just rhinosinusitis: clinical characteristics and phenotypes of patients with type 2 chronic rhinosinusitis with nasal polyps. Acta Biomed 2022;93:E2022240. https:\/\/doi.org\/10.23750\/abm.v93i4.12561"},{"key":"10.14639\/0392-100X-N2422_ref47","doi-asserted-by":"crossref","unstructured":"J CM, Miller C, Senior B. Management of chronic rhinosinusitis with nasal polyposis in the era of biologics. J Asthma Allergy 2021;14:873-882. https:\/\/doi.org\/10.2147\/JAA.S258438","DOI":"10.2147\/JAA.S258438"},{"key":"10.14639\/0392-100X-N2422_ref48","unstructured":"Reitsma S, Adriaensen G, Cornet ME, et al. The Amsterdam Classification of Completeness of Endoscopic Sinus Surgery (ACCESS): a new CT-based scoring system grading the extent of surgery. Rhinology 2020;58:538-543. https:\/\/doi.org\/10.4193\/Rhin20.165 Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics"},{"key":"10.14639\/0392-100X-N2422_ref49","doi-asserted-by":"crossref","unstructured":"Schalek P, Hart L, Fuksa J, et al. Quality of life in CRSwNP: evaluation of ACCESS and Lund-Mackay computed tomography scores vs the QoL questionnaire. Eur Arch Otorhinolaryngol 2022;279:5721-5725. https:\/\/doi.org\/10.1007\/s00405-022-07494-5","DOI":"10.1007\/s00405-022-07494-5"},{"key":"10.14639\/0392-100X-N2422_ref50","doi-asserted-by":"crossref","unstructured":"Aygun N, Zinreich SJ. Imaging for functional endoscopic sinus surgery. Otolaryngol Clin North Am 2006;39:403-416, vii. https:\/\/doi. org\/10.1016\/j.otc.2006.01.014","DOI":"10.1016\/j.otc.2006.01.014"},{"key":"10.14639\/0392-100X-N2422_ref51","doi-asserted-by":"crossref","unstructured":"Rimmer J, Fokkens W, Chong LY, et al. Surgical vs medical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev 2014;12:Cd006991. https:\/\/doi.org\/10.1002\/14651858.CD006991.pub2","DOI":"10.1002\/14651858.CD006991.pub2"},{"key":"10.14639\/0392-100X-N2422_ref52","doi-asserted-by":"crossref","unstructured":"Tanaka S, Tsuji T, Shiotsu S, et al. Exacerbation of eosinophilic granulomatosis with polyangiitis after administering dupilumab for severe asthma and eosinophilic rhinosinusitis with nasal polyposis. Cureus 2022;14:E25218. https:\/\/doi.org\/10.7759\/cureus.25218","DOI":"10.7759\/cureus.25218"},{"key":"10.14639\/0392-100X-N2422_ref53","doi-asserted-by":"crossref","unstructured":"Koike H, Nishi R, Yagi S, et al. A Review of Anti-IL-5 therapies for eosinophilic granulomatosis with polyangiitis. Adv Ther 2023;40:25-40. https:\/\/doi.org\/10.1007\/s12325-022-02307-x","DOI":"10.1007\/s12325-022-02307-x"},{"key":"10.14639\/0392-100X-N2422_ref54","doi-asserted-by":"crossref","unstructured":"Zhao WM, Wang ZJ, Shi R, et al. Environmental factors influencing the risk of ANCA-associated vasculitis. Front Immunol 2022;13:991256. https:\/\/doi.org\/10.3389\/fimmu.2022.991256","DOI":"10.3389\/fimmu.2022.991256"},{"key":"10.14639\/0392-100X-N2422_ref55","doi-asserted-by":"crossref","unstructured":"Trivioli G, Marquez A, Martorana D, et al. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management. Nat Rev Rheumatol 2022;18:559-574. https:\/\/doi.org\/10.1038\/s41584-022-00819-y","DOI":"10.1038\/s41584-022-00819-y"},{"key":"10.14639\/0392-100X-N2422_ref56","doi-asserted-by":"crossref","unstructured":"Pyo JY, Ahn SS, Song JJ, et al. The reclassification of patients with previously diagnosed eosinophilic granulomatosis with polyangiitis based on the 2022 ACR\/EULAR criteria for ANCA-associated vasculitis. J Rheumatol 2023;50:213-218. https:\/\/doi.org\/10.3899\/jrheum.220560","DOI":"10.3899\/jrheum.220560"},{"key":"10.14639\/0392-100X-N2422_ref57","doi-asserted-by":"crossref","unstructured":"Xu X, Reitsma S, Wang Y, et al. Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID-exacerbated respiratory disease. Allergy 2022;77:3593-3605. https:\/\/doi.org\/10.1111\/all.15507","DOI":"10.1111\/all.15507"},{"key":"10.14639\/0392-100X-N2422_ref58","doi-asserted-by":"crossref","unstructured":"Lee JU, Soo Chang H, Kyung Kim M, et al. Genome-wide DNA methylation profile of peripheral blood lymphocytes from subjects with nonsteroidal anti-inflammatory drug-induced respiratory diseases. Pharmacogenet Genomics 2022;32:226-234. https:\/\/doi.org\/10.1097\/FPC.0000000000000475","DOI":"10.1097\/FPC.0000000000000475"},{"key":"10.14639\/0392-100X-N2422_ref59","doi-asserted-by":"crossref","unstructured":"Bangert C, Villazala-Merino S, Fahrenberger M, et al. Comprehensive analysis of nasal polyps reveals a more pronounced type 2 transcriptomic profile of epithelial cells and mast cells in aspirin-exacerbated respiratory disease. Front Immunol 2022;13:850494. https:\/\/doi.org\/10.3389\/fimmu.2022.850494","DOI":"10.3389\/fimmu.2022.850494"},{"key":"10.14639\/0392-100X-N2422_ref60","doi-asserted-by":"crossref","unstructured":"Corey KB, Turner JH, Chowdhury NI, et al. Utility of nasal mucus inflammatory profile as a biomarker of nasal polyp regrowth in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract 2022;10:1644-1645 e1. https:\/\/doi.org\/10.1016\/j.jaip.2022.03.021","DOI":"10.1016\/j.jaip.2022.03.021"},{"key":"10.14639\/0392-100X-N2422_ref61","doi-asserted-by":"crossref","unstructured":"Wallace DV. Treatment options for chronic rhinosinusitis with nasal polyps. Allergy Asthma Proc 2021;42:450-460. https:\/\/doi.org\/10.2500\/aap.2021.42.210080","DOI":"10.2500\/aap.2021.42.210080"},{"key":"10.14639\/0392-100X-N2422_ref62","doi-asserted-by":"crossref","unstructured":"Bertlich M, Ihler F, Bertlich I, et al. Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desen-sitization or dupilumab. Medicine (Baltimore) 2021;100:E27471. https:\/\/doi.org\/10.1097\/MD.0000000000027471","DOI":"10.1097\/MD.0000000000027471"},{"key":"10.14639\/0392-100X-N2422_ref63","doi-asserted-by":"crossref","unstructured":"De Corso E, Settimi S, Montuori C, et al. Effectiveness of dupilumab in the treatment of patients with severe uncontrolled CRSwNP: a \u201cReal-Life\u201d observational study in the first year of treatment. J Clin Med 2022;11:2684. https:\/\/doi.org\/10.3390\/jcm11102684","DOI":"10.3390\/jcm11102684"},{"key":"10.14639\/0392-100X-N2422_ref64","doi-asserted-by":"crossref","unstructured":"De Corso E, Montuori C, Settimi S, et al. Efficacy of biologics on refractory eosinophilic otitis media associated with bronchial asthma or severe uncontrolled CRSwNP. J Clin Med 2022;11:926. https:\/\/doi.org\/10.3390\/jcm11040926","DOI":"10.3390\/jcm11040926"},{"key":"10.14639\/0392-100X-N2422_ref65","doi-asserted-by":"crossref","unstructured":"Ottaviano G, Saccardo T, Roccuzzo G, et al. Effectiveness of dupilumab in the treatment of patients with uncontrolled severe crswnp: a \u201cReal-Life\u201d observational study in naive and post-surgical patients. J Pers Med 2022;12:1526. https:\/\/doi.org\/10.3390\/jpm12091526","DOI":"10.3390\/jpm12091526"},{"key":"10.14639\/0392-100X-N2422_ref66","doi-asserted-by":"crossref","unstructured":"McNutt MK, Bradford M, Drazen JM, et al. Transparency in authors\u2019 contributions and responsibilities to promote integrity in scientific publication. PNAS 2018;115:2557-2560. https:\/\/doi.org\/10.1073\/pnas.1715374115","DOI":"10.31219\/osf.io\/asywp"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/2422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T03:22:02Z","timestamp":1729653722000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.actaitalica.it\/article\/view\/2422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":66,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-n2422","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"article-number":"4"}}